Ziopharm Oncology
ZIOP
#8755
Rank
S$0.23 B
Marketcap
S$1.11
Share price
-0.88%
Change (1 day)
-75.63%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -S$0.12 Billion

According to Ziopharm Oncology's latest financial reports the company's current earnings are S$3.73 Million. In 2020 the company made an earning of -S$0.11 Billion a decrease over its 2019 earnings that were of -S$73.81 Million.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-S$0.12 Billion16.92%
2020-S$0.11 Billion38.89%
2019-S$73.81 Million7.33%
2018-S$68.77 Million0.77%
2017-S$68.25 Million-67.64%
2016-S$0.22 Billion37.64%
2015-S$0.16 Billion176.1%
2014-S$55.5 Million-24.63%
2013-S$73.63 Million-43.51%
2012-S$0.14 Billion43.09%
2011-S$91.09 Million190.88%
2010-S$31.32 Million102.46%
2009-S$15.47 Million-52.68%
2008-S$32.69 Million-10.33%
2007-S$36.45 Million15.35%
2006-S$31.6 Million355.36%
2005-S$6.94 Million13788.35%
2004-S$0.05 Million9.27%
2003-S$0.05 Million-10.26%
2002-S$0.06 Million-59.35%
2001-S$0.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$11.45 B-10,154.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-S$0.65 Billion 465.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$11.89 B-10,548.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-S$3.52 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA